Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
提高低风险支气管活检评估的诊断率
基本信息
- 批准号:8531402
- 负责人:
- 金额:$ 55.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-19 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingBiopsyBiopsy SpecimenBreastBronchoscopesBronchoscopyCancer EtiologyCathetersCessation of lifeChestClinical ResearchColonDesmoplasticDetectionDevelopmentDiagnosisDiagnosticEarly DiagnosisEarly InterventionEnrollmentEnsureEvaluationExcision biopsyFibrosisFrequenciesGeneral HospitalsGoalsHistopathologyImageImage Guided BiopsyImaging DeviceImaging TechniquesLasersLeadLesionLibrariesLungMalignant NeoplasmsMalignant neoplasm of lungMassachusettsMedicalMicroscopicMicroscopyMolecular AnalysisMolecular ProfilingMorbidity - disease rateOperative Surgical ProceduresOpticsPathologistPathologyPatientsPeripheralPhysiciansProceduresProstatePulmonary Coin LesionResearch DesignResearch PersonnelResourcesRiskSafetySamplingSheepSiteSpecificitySpecimenSymptomsSystemTechniquesTestingTimeTissuesTrainingTranslatingTranslationsTumor TissueWorkX-Ray Computed Tomographyarmdesigndesign and constructiondiagnostic accuracyhigh riskimaging modalityimprovedin vivomortalitynoveloptical imagingpreclinical studyprototypepublic health relevancescreeningtooltranslational studytumor
项目摘要
DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer related death accounting for more deaths than breast, prostate and colon combined. Early diagnosis is critical to patient survival, however the vast majority of lung malignancies are detected only once symptoms arise and the cancer has spread, at which time patients have little chance of cure. Macroscopic imaging modalities including CT and bronchoscopy have made significant strides in increasing early detection; however they do not have the required specificity to diagnose malignancy. Diagnosis must be made on the microscopic level, which at present can only be accomplished with excisional biopsy. Unfortunately, low-risk bronchoscopic techniques for retrieving biopsy samples are hampered by low diagnostic yields, and trans-thoracic and surgical approaches carry higher intrinsic risk of complications. Given the very high false positive rates of these macroscopic imaging platforms it is imperative that high-risk procedures are avoided and the diagnostic accuracy of lower-risk approaches is greatly improved. In this proposal we aim to dramatically increase the diagnostic yield of low-risk bronchial biopsy using novel optical imaging tools to locally guide biopsy site selection ensuring that diagnostic quality
samples are obtained for both histopathology and molecular profiling. Specifically, we will develop and translate polarization-sensitive optical frequency domain imaging (PS-OFDI) systems, and novel catheters for conducting PS-OFDI of the airways and peripheral lung. We will develop and validate diagnostic criteria for evaluating the PS-OFDI images of lung cancer pathology, and we will conduct clinical studies to demonstrate the improvement in biopsy yield over conventional approaches. This work will leverage the expertise, resources and ongoing collaborative ties between investigators at Massachusetts General Hospital and NinePoint Medical. Together the strategic alliance already formed will ensure the successful translation and delivery of a powerful and robust new optical bronchoscopy tool that will likely result in an increase in the diagnostic yield of bronchial biopsy for the assessment of lung cancer.
描述(由申请人提供):肺癌是癌症相关死亡的主要原因,死亡人数比乳腺癌,前列腺和结肠合并更多。早期诊断对患者的生存至关重要,但是仅在症状出现并且癌症扩散后才检测到绝大多数肺部恶性肿瘤,此时患者几乎没有治愈的机会。包括CT和支气管镜在内的宏观成像方式在提高早期检测方面已取得了显着的进步。但是,它们没有必要的特异性来诊断恶性肿瘤。诊断必须在显微镜水平上进行,目前只能通过切除活检来完成。不幸的是,用于检索活检样品的低风险支气管镜技术受到低诊断产率的阻碍,而经胸腔和外科手术方法具有更高的并发症的内在风险。鉴于这些宏观成像平台的非常高的假阳性率必须避免高风险程序,并且低风险方法的诊断准确性大大提高了。在此提案中,我们旨在使用新颖的光学成像工具来大大提高低风险支气管活检的诊断产量
对于组织病理学和分子分析,获得样品。具体而言,我们将开发和翻译对极化敏感的光频域成像(PS-OFDI)系统,以及用于传导气道和周围肺PS-OFDI的新型导管。我们将开发和验证诊断标准,用于评估肺癌病理的PS-OFDI图像,我们将进行临床研究,以证明活检产量的提高而不是常规方法。这项工作将利用马萨诸塞州综合医院和尼尼波特医学的调查人员之间的专业知识,资源和持续的合作关系。共同组成的战略联盟将确保成功地翻译和交付强大而强大的新光学支气管镜工具,这可能会导致支气管活检的诊断产量增加,以评估肺癌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brett E Bouma其他文献
Brett E Bouma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brett E Bouma', 18)}}的其他基金
Dual-modality FLIm and PSOCT for intravascular imaging of plaque in patients
双模态 FLIm 和 PSOCT 用于患者斑块血管内成像
- 批准号:
10677774 - 财政年份:2021
- 资助金额:
$ 55.98万 - 项目类别:
Dual-modality FLIm and PSOCT for intravascular imaging of plaque in patients
双模态 FLIm 和 PSOCT 用于患者斑块血管内成像
- 批准号:
10306091 - 财政年份:2021
- 资助金额:
$ 55.98万 - 项目类别:
Center for Biomedical OCT Research and Translation
生物医学OCT研究与转化中心
- 批准号:
9521706 - 财政年份:2017
- 资助金额:
$ 55.98万 - 项目类别:
Intracoronary imaging of plaque collagen in patients
患者斑块胶原的冠状动脉内成像
- 批准号:
8735353 - 财政年份:2014
- 资助金额:
$ 55.98万 - 项目类别:
Intracoronary imaging of plaque collagen in patients
患者斑块胶原的冠状动脉内成像
- 批准号:
9263997 - 财政年份:2014
- 资助金额:
$ 55.98万 - 项目类别:
Intracoronary imaging of plaque collagen in patients
患者斑块胶原的冠状动脉内成像
- 批准号:
8842192 - 财政年份:2014
- 资助金额:
$ 55.98万 - 项目类别:
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
提高低风险支气管活检评估的诊断率
- 批准号:
8654306 - 财政年份:2013
- 资助金额:
$ 55.98万 - 项目类别:
Center for Biomedical OCT Research and Translation
生物医学OCT研究与转化中心
- 批准号:
10494619 - 财政年份:2011
- 资助金额:
$ 55.98万 - 项目类别:
Center for Biomedical OCT Research and Translation
生物医学OCT研究与转化中心
- 批准号:
8078519 - 财政年份:2011
- 资助金额:
$ 55.98万 - 项目类别:
相似国自然基金
肿瘤外泌体核酸甲基化标志物的鉴定及其在液体活检中的应用
- 批准号:22307101
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
基于微球透镜阵列的一体化检测芯片及其在肿瘤“液体活检”中应用的关键技术研究
- 批准号:62375121
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
近红外二区比率荧光双探针对转移前哨淋巴结的时间分辨活检
- 批准号:82302254
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于血浆cfDNA片段组学特征的液体活检技术在常见消化道肿瘤筛查中的应用研究
- 批准号:82373664
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于SERS光谱液体活检技术的鼻咽癌筛查研究
- 批准号:12374405
- 批准年份:2023
- 资助金额:53.00 万元
- 项目类别:面上项目
相似海外基金
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
指导非小细胞肺癌放疗使用的生物标志物驱动策略
- 批准号:
10518064 - 财政年份:2023
- 资助金额:
$ 55.98万 - 项目类别:
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
化生性乳腺癌 (MBC) 中 PI3K 和 NOS 通路的双重靶向
- 批准号:
10739097 - 财政年份:2023
- 资助金额:
$ 55.98万 - 项目类别:
Deep learning in cervical cancer radiogenomics
宫颈癌放射基因组学中的深度学习
- 批准号:
10643978 - 财政年份:2022
- 资助金额:
$ 55.98万 - 项目类别:
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
一项评估 PI3K/AKT 和 NOS 通路双重靶向治疗化生性乳腺癌 (MpBC) 的 II 期多中心试验
- 批准号:
10642669 - 财政年份:2022
- 资助金额:
$ 55.98万 - 项目类别:
Deep learning in cervical cancer radiogenomics
宫颈癌放射基因组学中的深度学习
- 批准号:
10424854 - 财政年份:2022
- 资助金额:
$ 55.98万 - 项目类别: